Watch CNBC's full interview with Mizuho's Salim Syed

Salim Syed, Mizuho senior biotech analyst, joins 'Squawk on the Street' to discuss biotech M&A in general, the Amgen Horizon Therapeutics acquisition, and the balance sheet concerns associated with Amgen.